Associate Director, Global Drug Safety and Pharmacovigilance Scientist

At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees. Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so. Does this inspire you and feel like a fit? Then we would love to have you join us! Genmab US, Inc. Associate Director, Global Drug Safety and Pharmacovigilance Scientist Location: Plainsboro, NJ Job Description The Associate Director, Global Drug Safety and Pharmacovigilance Scientist will be responsible for performing safety review of Adverse Event reports for Genmab products. Supporting high-priority, complex oncology development programs, including fast-tracked and pivotal programs such as Rinatabart sesutecan (Rina-S / GEN1184), from first-in-human through late-stage development and post-marketing. Providing strategic safety input for protocol amendments, risk mitigation strategies, and study design decisions based on emerging safety data from pivotal and registrational studies. Supporting Health Authority interactions related to safety signals, clinical holds, risk mitigation measures, and responses to regulatory questions for advanced-stage oncology programs. Leading or significantly contributing to safety strategy and documentation supporting pivotal development milestones and regulatory submissions. Playing an active role in cross-functional safety governance forums (e.g., Safety Committees, Risk Management Working Groups), including preparation and presentation of integrated safety analyses for senior stakeholders. Representing Global Drug Safety as a core member of Clinical Management Teams (CMTs) for complex oncology programs, providing expert safety guidance to clinical, regulatory, and operational stakeholders. Providing sponsor oversight of global CROs supporting pivotal oncology studies, ensuring quality, timeliness, and regulatory compliance of safety deliverables. Performing ongoing surveillance (including signal detection/evaluation) of Genmab clinical trials and post marketing safety data. Providing safety review and input to various documents including, but not limited to: Trial Protocols, eCRFs/CRFs, and TMFs as well as contributing to the development of other documentation such as Investigator’s Brochures, and Subject Informed Consent. Contributing to HA requests and reviewing key submission documents. Contributing to safety-related documents for Genmab products throughout the product lifecycle from FIH to post-marketing, including monthly safety surveillance, Safety Assessment Reports for potential signals/risks, RSI in IB, ADR in the CCDS and product labels, Aggregate Safety Reports (e.g. DSUR, PBRER, PSUR, PAER), RMP, and responses to ad-hoc requests for safety information internally and externally. Contributing to the planning and conduct of Safety Committee activities and DMC’s. Conducting safety training of Genmab employees, CROs, Investigators and other relevant site personnel as necessary. Contributing to multidisciplinary project groups including membership of the Clinical Management Team (CMT) for assigned products. Contributing to the development and optimization of new tools and processes. Interacting with safety and clinical CROs, performing sponsor oversight activities for safety related tasks, process invoices, and ensuring regulatory compliance (including regulatory reporting requirements) for assigned products. Supporting review of Safety Data Exchange Agreements with partners as required. Performing ongoing surveillance of new and updated regulations/guidelines and assessing the impact on drug safety processes at Genmab. Ensuring compliance with regulatory guidelines and internal processes and procedures in preparation of audits and inspections. Participating in audit and inspection activities as required. Annual salary between: $223142 - $243,960.00. Job Requirements Requires a Bachelor’s degree (or foreign equivalent) in Pharmacy, Chemistry, or a related natural sciences field plus at least 7 years (84 months) of experience with drug safety and pharmacovigilance in the pharmaceutical industry for products in clinical trial and postmarketing environments. Must possess at least 7 years (84 months) of progressive post-baccalaureate experience with all of the following: (a) first human trials; (b) overseeing multiple trials with safety inputs at the global level; (c) collaborating with cross-functional teams to continuously improve the efficiency of quality control processes, contributing to audit readiness and ensuring alignment with both client expectations and regulatory requirements; (d) performing ongoing surveillance (including signal detection and evaluation) of safety data; (e) ensuring compliance with regulatory guidelines and internal processes and procedures in order to be prepared for audits and inspections; (f) international experience with internal and external stakeholders; and (g) Argus Safety Database. Experience may be gained concurrently. Position may allow working from home within commuting distance of worksite location. For US based candidates, the proposed salary band for this position is as follows: $0.00---$0.00 The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives. When you join Genmab, you’re joining a culture that supports your physical, financial, social, and emotional wellness. Within the first year, regular full-time U.S. employees are eligible for: 401(k) Plan: 100% match on the first 6% of contributions Health Benefits: Two medical plan options (including HDHP with HSA), dental, and vision insurance Voluntary Plans: Critical illness, accident, and hospital indemnity insurance Time Off: Paid vacation, sick leave, holidays, and 12 weeks of discretionary paid parental leave Support Resources: Access to child and adult backup care, family support programs, financial wellness tools, and emotional well-being support Additional Perks: Commuter benefits, tuition reimbursement, and a Lifestyle Spending Account for wellness and personal expenses About You You are genuinely passionate about our purpose You bring precision and excellence to all that you do You believe in our rooted-in-science approach to problem-solving You are a generous collaborator who can work in teams with a broad spectrum of backgrounds You take pride in enabling the best work of others on the team You can grapple with the unknown and be innovative You have experience working in a fast-growing, dynamic company (or a strong desire to) You work hard and are not afraid to have a little fun while you do so! Locations Genmab maximizes the efficiency of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are crafted as open, community-based spaces that work to connect employees while being immersed in our powerful laboratories. Whether you’re in one of our office spaces or working remotely, we thrive on connecting with each other to innovate. About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines. Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X. Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com). Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract. Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO™) antibody medicines. Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.